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Objectives: The interaction of hydroxyurea (HU) with serum albumins (SAs) has not been investigated so far.
However, it necessitates the interaction study of HU with SAs in phosphate buffer of pH 7.4.
Methods: The binding of HU on bovine serum albumin (BSA) and human serum albumin (HSA) was studied
in vitro under simulated physiological conditions by spectroscopic methods viz., fluorescence, FT-IR, UV–vis
absorption, synchronous fluorescence and three-dimensional fluorescence.
Results: The Stern-Volmer plot indicated the presence of dynamic quenching mechanism in the interaction of HU
with SAs. The number of binding sites, n and binding constants, K were obtained at various temperatures according
to the double logarithm regression curve. The result of FT-IR spectra, UV–vis absorption, synchronous fluorescence
and three-dimensional fluorescence spectra showed that the conformation of SAs has been changed in the
presence of HU. The thermodynamic parameters were calculated according to van’t Hoff equation and discussed.
Conclusion: This kind of study of interaction between BSA and HSA with HU would be useful in pharmaceutical
industry, life sciences and clinical medicine.
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It is known that the distribution, free concentration and
the metabolism of various drugs are strongly affected by
drug–protein interactions in the blood stream (Hu et al.
2005; Kamat 2005; Naik et al. 2009). This type of inter-
action can also influence the drug stability and toxicity
during the chemotherapeutic process (Hu et al. 2005).
Serum albumin is the most abundant protein present in
the circulatory system of a wide variety of organisms and
being major macromolecule it contributes to osmotic
blood pressure (Carter & Ho 1994). It can play a dominant
role in drug disposition and efficiency (Olson & Christ
1996). Many drugs and other bioactive small molecules
bind reversibly to albumin and other serum components,
which then function as carriers. Serum albumin often
increases the apparent solubility of hydrophobic drugs
in plasma and modulates their delivery to cell in vivo* Correspondence: stnandibewoor@yahoo.com
P. G. Department of Studies in Chemistry, Karnatak University, Dharwad 580
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in any medium, provided the original work is pand in vitro. Animal experiments are indispensable in
providing basic information on the pharmacological
actions, biotransformation and biodistribution of drugs
(He & Carter 1992; Guo et al. 2004). Bovine serum albu-
min (BSA) (Figure 1) is well suited to these initial studies,
since it has been extensively characterized (Guo et al.
2004). Similarly human serum albumin (HSA) (Figure 1)
as the most abundant carrier protein plays an important
role in the transport and disposition of many endogenous
and exogenous substances such as metabolites, drugs, and
other biologically active compounds present in blood
(Carter & Ho 1994). Recently, its three-dimensional
(3D) structure has been determined through X-ray crystal-
lographic measurements (Carter & Ho 1994) and consists
of three structurally homologous domains which assemble
to form a heart-shaped molecule, each domain contains
two sub-domains. Serum albumin binds and transports
many ligands, including fatty acids, amino acids, hor-
mones, cations, anions, and variety of pharmaceuticals.
It is suggested that the principal regions of ligand bindingOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Figure 1 Structure of BSA and HSA.
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domains IIA and IIIA, which are consistent with sites I
and II, respectively, and single tryptophan residue of HSA
is in subdomain IIA (Carter & Ho 1994; He & Carter
1992). In addition, drug–albumin complex may be consid-
ered as a model for gaining general fundamental insights
into drug–protein binding. Plasma protein binding of
drugs assumes great importance since it influences their
pharmacokinetic and pharmacodynamic properties, and
may also cause interference with the binding of other
endogenous and/or exogenous ligands as a result of
overlap of binding sites and/or conformational changes.
Therefore, detailed investigation of drug–protein inter-
action assumes significance for thorough understanding
of the pharmacokinetic behavior of a drug and for the
design of analogues with effective pharmacological
properties. Fluorescence quenching is a useful method
to study the reactivity of chemical and biological
systems since it allows non-intrusive measurements of
substances in low concentration under physiological
conditions (Naik et al. 2010; Gu et al. 2007). It can reveal
accessibility of quenchers to serum albumins fluorophores,
help to understand serum albumins binding mechanisms
to compounds and provides clues to the nature of the
binding phenomenon. Fourier transform infrared (FT-
IR spectroscopy), a powerful technique for the study of
hydrogen bonding, has recently become very popularScheme 1 Structural formula of hydroxyurea.for structural characterization of proteins. The most im-
portant advantage of FT-IR spectroscopy for biological
studies is that spectra of almost any biological system
can be obtained in a wide verity of environments.
Hydroxyurea (HU), the simplest, 1-carbon organic
antitumor agent, is a member of the substituted urea
group and is chemically known as hydroxycarbamide
(Donehower 1990). In 1981 it was reported to have
antineoplastic activity against sarcoma (Van Belle et al.
1986). At present, the primary role of hydroxyurea
(Scheme 1) in chemotherapy is the management of
granulocytic leukemia and thrombocytosis. It has been
used in combination with radiotherapy for carcinomas
of the head and neck (Heerenberg 1992). HU is used in
the treatment of cancer (Donehower 1992), sickle cell
anemia (Charache et al. 1992) and infection with the
human immunodeficiency virus (HIV) (Gao et al. 1993).
HU is a potent, nonalkylating myelosuppressive agent that
inhibits DNA synthesis (Krakoff et al. 1968).
The interaction of HU with SAs has not been investi-
gated so far. However, it necessitates the interaction study
of HU with SAs in phosphate buffer of pH 7.4. Different
aspects of HU-serum albumin interactions viz., quenching
mechanism, binding force operating between the drug and
proteins, the distance of separation between the protein
and HU (based on the theory of fluorescence resonance
energy transfer), conformational changes etc. have been
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interaction of HU with SAs employing fluorescence
spectroscopy, UV–vis absorption, FT-IR, synchronous




Bovine serum albumin (BSA) and human serum albumin
(HSA) were purchased from Sigma Chemical Company,
St. Louis, USA and used without purification. Hydroxy-
urea (HU) was obtained from Sigma Aldrich. The solu-
tions of HU, BSA and HSA were prepared in 0.1 M
phosphate buffer of pH 7.4 with respect to their molecular
weight. All other materials were of analytical reagent grade
and Millipore water was used throughout the work.
Instrumentation used
Fluorescence spectra were recorded using a RF-5301 PC
Hitachi spectrofluorometer Model F-2000 (Tokyo, Japan)
with a 150 W Xenon lamp, a 1 cm quartz cell and
thermostatic cuvette holder. The excitation and emis-
sion bandwidths were both 5 nm. The temperature of the
sample was maintained by recycling water throughout the
experiment. The absorption spectra were recorded on a
singlet beam CARY 50-BIO UV–vis. Spectrophotometer
(Victoria, Australia), FT-IR Nicolet-5700 (USA) was used
to record infrared spectra. All of the pH measurements
were performed with an Elico LI120 pH meter (Elico Ltd.,
India).
Procedures
Hydroxyurea with protein interaction study
A stock solution of 250 μM of BSA, HSA and HU were
prepared in phosphate buffer solution (pH 7.4). An
appropriate volume of BSA or HSA to obtain 5 μM
and 5 μM HU was mixed and fluorescence spectra
were recorded. In the next step fixing the concentra-
tion of HSA at 5 μM and drug concentration was var-
ied from 5 to 45 μM. Fluorescence spectra were
recorded at three different temperatures (288, 298 and
308 K) in the range 300–450 nm upon excitation at
295 and 280 nm in BSA and HSA case.
Absorption measurements
The UV measurements of BSA and HSA in the presence
and absence of HU were made in the range of 240–
340 nm. BSA and HSA concentration was fixed at 5 μM
while the drug concentration was varied from 5 to 10 μM
in presence of phosphate buffer at 298 K.
FT-IR measurements
The FT-IR spectra of BSA and HSA in presence and
absence of HU at 298 K were recorded in the range of1600 – 3000 cm−1. Serum albumins concentration was
fixed at 5 μM while that of HU was 20 μM in presence
of phosphate buffer.
Synchronous fluorescence measurements
The synchronous fluorescence characteristics of HU-SAs
were noted down at different scanning intervals of Δλ
(Δλ = λem - λex). When Δλ = 15 nm, the spectrum char-
acteristics of protein tyrosine residues were observed
and when Δλ = 60 nm, the spectrum characteristics of
protein tryptophan residues were noticed.
3-D fluorescence studies
3-D fluorescence spectrum was recorded under the fol-
lowing conditions: excitation wavelength range of 250–
350 nm and emission wavelength range of 200–500 nm
and an increment of 10 nm with other parameters were
just the same as that of fluorescence quenching spectra.
Cprotein = 5 μM and CHU = 20 μM.
Effects of some common ions
The effects of some common ions viz., Co2+, Cu2+, Ni2+,
Ca2+ and Zn2+ were investigated on HU with BSA and
HSA interactions. The fluorescence spectra of HU with
BSA or HSA system were recorded in presence of above
ions at excitation at 295 and 280 nm for BSA and HSA
at 298 K. The overall concentration of BSA or HSA and
that of the common ions were fixed at 5 μM, while the
concentration of HU was varied from 0 to 45 μM at
298 K.
Results and discussion
Analysis of fluorescence quenching of serum albumins by
hydroxyurea
Fluorescence quenching is the decrease of the quantum
yield of fluorescence from a fluorophore induced by a var-
iety of molecular interactions with a quencher molecule.
Generally, the fluorescence of serum albumins comes
from tryptophan, tyrosine and phenylalanine residues. The
intrinsic fluorescence of BSA and HSA is almost due to
tryptophan alone because phenylalanine has a very low
quantum yield and the fluorescence of tyrosine is almost
totally quenched if it is ionized or near an amino group, a
carboxyl group or a tryptophan. This viewpoint was well
supported by the experimental observations of Sulkowska
(Sulkowska 2002). That is, the change of intrinsic fluores-
cence intensity of BSA and HSA was due to tryptophan
residue when small molecules bound to BSA and HSA.
When different amounts of drug solution were titrated
with a fixed concentration of SAs, a remarkable decrease
in the fluorescence intensity of SAs was observed with
hydroxyurea (Figure 2) in the present study. Under the
experimental conditions, hydroxyurea did not show any





























Figure 2 Fluorescence spectra of BSA and HSA. A. Fluorescence spectra of BSA (5 μM) in presence of HU: (a) 0 μM, (b) 5 μM, (c) 10 μM, (d) 15 μM,
(e) 20 μM, (f) 25 μM, (g) 30 μM, (h) 35 μM, (i) 40 μM, (j) 45 μM. B. Fluorescence spectra of HSA (5 μM) in presence of HU: (a) 0 μM, (b) 5 μM, (c) 10 μM,
(d) 15 μM, (e) 20 μM, (f) 25 μM, (g) 30 μM, (h) 35 μM, (i) 40 μM, (j) 45 μM.
Naik et al. SpringerPlus 2014, 3:360 Page 4 of 13
http://www.springerplus.com/content/3/1/360wavelength of BSA and HSA observed upon the addition
of hydroxyurea was probably due to the loss of the com-
pact structure of hydrophobic sub-domain where trypto-
phan was placed (Sulkowska 2002).
Binding parameters and mechanism
Quenching can be induced by dynamic and static process.
Dynamic and static quenching can be distinguished
based on their differences on temperature dependence.
Higher temperature results in faster diffusion and larger
amounts of collisional quenching. It will typically lead
to the dissociation of weakly bound complexes and
smaller amounts of static quenching. Therefore, the
quenching constant increases for dynamic quenchingwhile it decreases for static quenching with increase in
temperature. In order to invoke this possible quenching
mechanism, the fluorescence quenching data were
subjected to Stern–Volmer analysis using the equation:
(Lakowicz 1999)
Fo=F ¼ 1þ KSV Q½  ¼ 1þ KqΓo Q½  ð1Þ
where F and Fo are the fluorescence intensity of BSA
or HSA with and without quencher (drug), respec-
tively. Kq, KSV, Γo and [Q] are the quenching rate con-
stant of the biomolecule, the dynamic quenching
constant, the average lifetime of the biomolecule without
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tively. Obviously,
Kq ¼ KSV=Γo ð2Þ
The Stern–Volmer plots for representative HU–SAs
systems are shown in Figure 3. The Stern–Volmer plots
were observed to be linear in both BSA and HSA with HU.
The slopes were increasing in both HU-BSA and HU-HSA
systems with increase in temperature. The values of KSVFigure 3 The Stern–Volmer plots with BSA and HSA. A. The Stern–Volm
K (c). B. The Stern–Volmer plots for quenching of HU with HSA at 288 K (a)at different temperatures were evaluated and are given
in Tables 1 and 2. The values of KSV at different tempera-
tures indicated that the presence of dynamic quenching
mechanism in both the interaction between BSA and HSA
with HU.
Since the fluorescence lifetime of the biopolymer (Chen
et al. 1990) is 10−8 s, the quenching rate constant, Kq can
be calculated using the above equation. The values of Kq
are given in Tables 1 and 2. The maximum scatter colli-
sion quenching constant, Kq of various quenchers wither plots for quenching of HU with BSA at 288 K (a), 298 K (b) and 308
, 298 K (b) and 308 K (c).
Table 1 Interaction parameters of HU-BSA system at different temperatures
Temp. (K) Ksv × 10−4 M−1 Kq × 10−12 M−1S−1 Binding constant
K × 10−4 M−1






288 0.3966 0.3966 1.5049 1.15
298 0.6941 0.6941 3.1754 1.15 58.08 ± 2.0 281.47 ± 13.0 −25.79 ± 3.0
308 1.0150 1.0150 7.2795 1.19
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be 2 × 10 (Donehower 1990) LM−1 S−1. The order of mag-
nitude of Kq was calculated to be 10 (Heerenberg 1992)
for both BSA and HSA with HU systems in the present
study. So, the rate constants of the protein quenching pro-
cedure initiated by HU are greater than the value of Kq for
the scatter mechanism.
Binding parameters
Fluorescence intensity data can also be used to obtain
the binding constant, K and the number of binding
sites, n. When small molecules bind independently to a
set of equivalent sites on a macromolecule, the equilib-
rium between free and bound molecules is given (Wang
et al. 2007) by the following equation.
log Fo‐Fð Þ=F ¼ logKþ nlog Q½  ð3Þ
The values of K and n were obtained from the inter-
cept and slope of the plot of log [(Fo - F)/F] vs. log [Q]
(Figure 4) and are given in Tables 1 and 2. The value of
K is significant to understand the distribution of the
drug in plasma since the weak binding can lead to a
short lifetime or poor distribution, while strong binding
can decrease the concentrations of free drug in plasma.
It was noticed that the binding constant values increased
with the increase in temperature in HU and BSA or
HSA interactions. These results indicate that there is a
higher binding affinity and much more stable complex
between HU with BSA or HSA. The value of n is helpful
to know the number of binding sites and to locate the
binding site in BSA and HSA for the drug. The values of
n for HU with BSA and HSA were noticed to be almost
unity indicating that there were one independent class
of binding sites on BSA and HSA with HU. Hence, the
HU most likely bound to the hydrophobic pocket
located in sub-domain IIA; that is to say Trp 214 is near
or within the binding site (Hong et al. 2004).Table 2 Interaction parameters of HU-HSA system at differen
Temp. (K) Ksv × 10−4 M−1 Kq × 10−12 M−1S−1 Binding constant
K × 10−4 M−1
288 0.5042 0.5042 1.1601
298 0.8949 0.8949 4.3863
308 1.1019 1.1019 18.958Thermodynamic parameters and the nature of binding
forces
The thermodynamic parameters, free energy change
(ΔG0), enthalpy change (ΔH0) and entropy change
(ΔS0) of HU with BSA and HSA interaction are import-
ant for confirming binding mode. For this purpose, the
temperature dependence of binding constant was stud-
ied. Binding studies were carried out at 288, 298 and
308K at which SAs does not undergo any structural
degradation. The molecular forces contributing to pro-
tein interactions with small molecular substrates may
include van-der Waals interactions, hydrogen bonds,
electrostatic and hydrophobic interactions and so on
(Ulrich 1981). The thermodynamic parameters were
evaluated using the van’t Hoff equation and Gibbs–
Helmholtz equation:
log K ¼ ‐ΔH0=2:303 RTþ ΔS0=2:303R ð4Þ
ΔG0 ¼ ΔH0 ‐TΔS0 ð5Þ
The plot of log K versus 1/T (Figure 5) enabled the
determination of the values of ΔH0 and ΔS0. Ross and
Subramanian (Ross & Subramanian 1981) have charac-
terized the sign and magnitude of the thermodynamic
parameters associated with various individual kinds of
interaction. For typical hydrophobic interactions, both
ΔH0 and ΔS0 are positive, while these are negative for
van-der Waals forces and hydrogen-bond formation in
low dielectric media (Ross & Subramanian 1981; Mallick
et al. 2005). Moreover, the specific electrostatic interaction
between ionic species in an aqueous solution is character-
ized by positive ΔS0 value and negative ΔH0 value (small).
For HU–SA complex, the main source of ΔG0 value was
derived from a large contribution of ΔS0 term with a little
contribution from ΔH0 factor. So, the main interaction be-
tween HU–SAs was believed to be hydrophobic. However,
the electrostatic interaction could not be excluded. Negativet temperatures







1.17 102.94 ± 3.0 434.95 ± 12.0 −26.67 ± 2.0
1.28
Figure 4 The plot of log of BSA and HSA. A. The plot of log (Fo-F)/F vs log [Q] for quenching of BSA by HU at 288 K (a), 298 K (b) and 308 K
(c). B. The plot of log (Fo-F)/F vs log [Q] for quenching of HSA by HU at 288 K (a), 298 K (b) and 308 K (c).
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spontaneity of interaction.
Absorption spectroscopic studies
UV–vis absorption measurement is a very simple method
and applicable to know the change in hydrophobicity
(Wang et al. 2007) and to know the complex formation
(Valeur 2001). In the present study, we have observed
the change in UV absorption spectra of BSA, HSA and
HU–SAs systems (Figure 6). Due to the shift in λmax, a
formation of complex between HU and serum albumins
(Bi et al. 2005) was suggested. It is evident that the UVabsorption intensity of serum albumins increased regularly
with the increase in concentration of HU. The change in
λmax also indicates the change in polarity around the tryp-
tophan residue and the change in peptide strand of BSA
and HSA molecule and hence the change in hydrophobi-
city (Shaikh et al. 2007).
FT-IR spectroscopic studies
Additional evidence for HU-SAs interactions were ob-
tained from FT-IR spectra. Infrared spectrum of protein
exhibited a number of amide bands due to different vi-
brations of the peptide moiety. Of all the amide modes
Figure 5 Van’t Hoff plot with BSA and HSA. A. van’t Hoff plot for the binding of HU with BSA. B. van’t Hoff plot for the binding of HU with HSA.
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studies of protein secondary structure is the amide I. The
amides I and II peaks occurred in the region of 1600 –
1700 cm−1 and 1500 – 1600 cm−1, respectively (Figure 7).
Amide I band is more sensitive to changes in protein sec-
ondary structure compared to amide II. Hence, the amide
I is more useful for studies of secondary structure (Wi
et al. 1998; Rahmelow & Hubner 1996). The FT-IR
spectrum reveals that the peak position of amide I was
shifted from 1641 to1651 cm−1 in the IR spectrum of BSA
upon interaction with HU and 1651 to1643 cm−1 in the IR
spectrum of HSA upon interaction with HU. This indi-
cated that the HU interacted with BSA and HSA and the
secondary structure of SAs was changed.Synchronous fluorescence spectra
Synchronous fluorescence spectra provide information on
the molecular environment of the fluorophore functional
group. The value of Δλ i.e. difference between excitation
and emission wavelengths is an important operating
parameter. According to Miller (Miller 1979) when Δλ
is 15 nm, synchronous fluorescence spectra indicates the
changes in the microenvironment of tyrosine residues and
when Δλ is 60 nm, it provides information on the micro-
environment of tryptophan residues. With the unchanged
concentration of the BSA, HSA and the concentration of
HU increased by titration, the synchronous spectroscopy
were performed at Δλ = 15 nm and Δλ = 60 nm and are
shown in Figure 8 (only Δλ = 60 nm were given).
Figure 6 Absorbance spectra of BSA and HSA. A. Absorbance spectra of BSA, HU and HU-BSA system. BSA concentration was 5 μM (a). HU
concentration for HU–BSA system was at 5 μM (b) and 10 μM (c). (x) is the concentration of 5 μM HU. B. Absorbance spectra of HSA, HU and
HU-HSA system. HSA concentration was 5 μM (a). HU concentration for HU–HSA system was at 5 μM (b) and 10 μM (c). (x) is the concentration
of 5 μM HU.
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of tryptophan residues decreased faster than that of tyro-
sine residues, which revealed that tryptophan residues
contributed more to the quenching of intrinsic BSA and
HSA florescence in both the system. In addition, a slight
red shift observed in both the tyrosine and tryptophan
residues, indicated the less hydrophobic environment
and more exposed to the solvent molecules during the
binding process in both the systems. So both the micro-
environment of tyrosine and tryptophan residues was
changed, resulting in conformational changes of BSA
and HSA during the binding process (Liu et al. 2001;
Zhang et al. 2008).
Three-dimensional fluorescence spectra
Three-dimensional fluorescence spectra have become
a popular fluorescence analysis technique in recent
years (Weber 1961). It is well known that three-
dimensional fluorescence spectrum can provide moredetailed information about the change of the configu-
ration of proteins. In addition, the contour map can
also provide a lot of important information. Figure 9A
presents the three-dimensional fluorescence spectra
and contour ones of BSA (A) and BSA-HU (B) and
Figure 9B presents the three-dimensional fluorescence
spectra and contour ones of HSA (A) and HSA-HU (B),
respectively. The contour map displayed a bird’s eye view
of the fluorescence spectra. In both the Figures 9A and B,
peak a is the Rayleigh scattering peak (λex = λem) (Zhang &
Mei 2009). With the addition of HU, the fluorescence
intensities of peak a increased. The reason for this is
that when the HU-SAs complex was formed, it caused
the diameter of the macromolecule to increase which in
turn resulted in enhanced scattering effects.
As referred to peak 1, it mainly reveals the spectral
characteristic of tryptophan and tyrosine residues. The
reason is that when serum albumin is excited at 280 nm
for BSA and 280 nm for HSA, it mainly reveals the
(A)
(B)
Figure 7 FT-IR spectra of (A) BSA-HU system and (B) HSA-HU system.
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while fluorescence by the phenylalanine (Phe) residue is
negligible. Compared with UV absorption spectrum of
SAs (Figure 6), there is an absorption peak at around 295
nm for BSA and 280 nm for HSA, which is mainly in-
duced by the π→ π * transition of an aromatic amino acid.
The Trp, Tyr and Phe residues in the binding cavity of
protein have conjugated π - electrons and thus easily form
charge transfer compounds with electron deficient species
or other π - electron systems (Kang et al. 2004). The fluo-
rescence intensity of the peak 1 decreased markedly and
the maximum emission wavelengths of the peak 1 have
obvious blue shift following the addition of HU, indicating
that the conformations of the tryptophan and tyrosine res-
idues of BSA and HSA were altered. Therefore, we can
conclude that the binding of HU-SAs induced some micro
environmental and conformational changes in BSA and
HSA, a complex between HU-SAs has been formed.
Effect of metal ions on the interactions of serum
albumins by hydroxyurea
In plasma, there are some metal ions, which can affect
the interactions of the drugs and serum albumins. Tracemetal ions, especially the bivalent type are essential in the
human body and play an important structural role in
many proteins. It is reported (Kang et al. 2004) that Cu2+,
Zn2+, Ni2+, Co2+ and Ca2+ and other metal ions can form
complexes with serum albumins. Hence, the effects of
some metal salt solutions viz., CuCl2, ZnCl2, NiCl2, CoCl2
and CaCl2 on the binding of HU with BSA and HSA were
investigated in the present study. Under the experimental
conditions, none of the cations gave the precipitate in
phosphate buffer. The binding constants of HU with BSA
and HSA in presence of above ions were evaluated and
the results are shown in Table 3. The binding constant
of HU-BSA system decreased in presence of Cu2+, Ca2+,
Zn2+ and Ni2+, whereas in HU-HSA system, the binding
constant decreased in presence of Co2+, Ca2+, Zn2+ and
Ni2+. This was likely to be caused by a conformational
change in the vicinity of the binding site. The decrease
in the binding constant in presence of above metal ions
would shorten the storage time of the drug in blood
plasma and hence more amount of free drug would be
available in plasma (Shaikh et al. 2007). This led to the
need for more doses of drug to achieve the desired
therapeutic effect in presence of above ions. The
Figure 8 Synchronous fluorescence spectra of BSA and HSA. A. Synchronous fluorescence spectra of BSA-HU: For Δλ = 60 nm. Concentration
of HU: (a) 0, (b) 5, (c) 10, (d) 15, (e) 20 and (f) 25 μM. The concentration of BSA was 5.0 μM. B. Synchronous fluorescence spectra of HSA-HU:
(A) For Δλ = 60 nm. Concentration of HU: (a) 0, (b) 5, (c) 10, (d) 15, (e) 20, (f) 25 and (g) 30 μM. The concentration of HSA was 5.0 μM.
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BSA system, while Cu2+ in the HU-BSA system which
indicates the formation of metal ion-drug complex via
metal ion bridge. This led to the need for less dose of
drug for desired therapeutic effect. This may prolong
storage period of HU in blood plasma and enhance its
maximum effects.
Comparison of two systems
The values of binding constants (Table 1) suggest the
interaction of HU with BSA and HSA are almost similar
fashion. The quenching mechanism is also similar in
both the system i.e., dynamic quenching. The binding
sites were unity in both the systems. The thermo-
dynamic parameters revealed that the HU and BSA and
HSA undergo hydrophobic interaction. The synchronousfluorescence spectra and three dimensional fluorescence
spectra reveals that the microenvironment of tyrosine
and tryptophan residues was changed, resulting in
conformational changes of SAs during the binding process.
Conclusions
The present work provides an approach for studying the
interactions of BSA and HSA with hydroxyurea using
absorption, fluorescence, FT-IR, synchronous and 3-D
fluorescence techniques under physiological conditions.
The results showed that BSA and HSA fluorescence was
quenched by HU through dynamic quenching mechanism.
HU interacted with SAs through hydrophobic forces. The
remarkable change of amide I peak position in the BSA
and HSA infrared spectrum after interaction with HU
indicated that secondary structure of BSA and HSA has
Figure 9 The 3-D fluorescence spectra of BSA and HSA. A. The 3-D fluorescence spectra and corresponding contour diagrams of BSA (A) and
BSA-HU (B). The concentration of protein was 5 μM and that of HU was 20 μM. B. The 3-D fluorescence spectra and corresponding contour
diagrams of HSA (A) and HSA-HU (B). The concentration of protein was 5 μM and that of HU was 20 μM.
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Table 3 Effect of common ions on binding constant of
HU-BSA and HU-HSA systems
Systems Binding constant (M−1)
BSA HSA
HU 3.1754 × 104 4.3863 × 104
HU + Co2+ 2.08 × 105 4.18 × 104
HU + Ni2+ 2.74 × 104 3.74 × 104
HU + Ca2+ 3.13 × 104 3.83 × 104
HU + Zn2+ 2.98 × 104 4.08 × 104
HU + Cu2+ 2.86 × 104 3.26 × 105
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standardized screens for protein binding in the first
step of new drug design, this kind of study of inter-
action between BSA and HSA with HU would be useful
in pharmaceutical industry, life sciences and clinical
medicine.
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